HRP20090647T1 - Novi derivati 3-fenilpropionske kiseline i nihova uporaba kao ppar-gama receptorskih liganada - Google Patents
Novi derivati 3-fenilpropionske kiseline i nihova uporaba kao ppar-gama receptorskih liganada Download PDFInfo
- Publication number
- HRP20090647T1 HRP20090647T1 HR20090647T HRP20090647T HRP20090647T1 HR P20090647 T1 HRP20090647 T1 HR P20090647T1 HR 20090647 T HR20090647 T HR 20090647T HR P20090647 T HRP20090647 T HR P20090647T HR P20090647 T1 HRP20090647 T1 HR P20090647T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- compound according
- phenyl
- aryl
- amino
- Prior art date
Links
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical class OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 title claims 2
- 239000003446 ligand Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 28
- 125000001424 substituent group Chemical group 0.000 claims abstract 8
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 4
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims abstract 4
- 102000000536 PPAR gamma Human genes 0.000 claims abstract 3
- 108010016731 PPAR gamma Proteins 0.000 claims abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 3
- 201000010099 disease Diseases 0.000 claims abstract 2
- 230000001404 mediated effect Effects 0.000 claims abstract 2
- 238000011282 treatment Methods 0.000 claims abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- -1 C1-C4- alkoxy Chemical group 0.000 claims 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000005699 methyleneoxy group Chemical group [H]C([H])([*:1])O[*:2] 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- RHHNRXBCUAHOLI-DEOSSOPVSA-N (2s)-3-[4-[2-[cyclohexanecarbonyl(methyl)amino]ethoxy]phenyl]-2-[(4-phenyl-1,3-thiazol-2-yl)amino]propanoic acid Chemical compound N([C@@H](CC1=CC=C(C=C1)OCCN(C)C(=O)C1CCCCC1)C(O)=O)C(SC=1)=NC=1C1=CC=CC=C1 RHHNRXBCUAHOLI-DEOSSOPVSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical group CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 230000037356 lipid metabolism Effects 0.000 claims 1
- RPXLWSZUGRYWGV-VWLOTQADSA-N methyl (2s)-3-[4-[2-[cyclohexanecarbonyl(methyl)amino]ethoxy]phenyl]-2-[(4-phenyl-1,3-thiazol-2-yl)amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC=1SC=C(N=1)C=1C=CC=CC=1)C(C=C1)=CC=C1OCCN(C)C(=O)C1CCCCC1 RPXLWSZUGRYWGV-VWLOTQADSA-N 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL372332A PL372332A1 (pl) | 2005-01-19 | 2005-01-19 | Nowe związki, pochodne kwasu 3-fenylopropionowego |
PCT/EP2006/050234 WO2006077206A1 (en) | 2005-01-19 | 2006-01-17 | New 3-phenylpropionic acid derivatives and their use as ppar- gamma rezeptor liganden |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090647T1 true HRP20090647T1 (hr) | 2010-01-31 |
Family
ID=36046977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090647T HRP20090647T1 (hr) | 2005-01-19 | 2009-12-04 | Novi derivati 3-fenilpropionske kiseline i nihova uporaba kao ppar-gama receptorskih liganada |
Country Status (25)
Country | Link |
---|---|
US (2) | US7309791B2 (es) |
EP (1) | EP1874745B1 (es) |
JP (1) | JP2008527021A (es) |
KR (1) | KR100889447B1 (es) |
CN (1) | CN101098862A (es) |
AT (1) | ATE448214T1 (es) |
AU (1) | AU2006207492B8 (es) |
BR (1) | BRPI0606501A2 (es) |
CA (1) | CA2590575C (es) |
CY (1) | CY1109678T1 (es) |
DE (1) | DE602006010353D1 (es) |
DK (1) | DK1874745T3 (es) |
ES (1) | ES2336358T3 (es) |
HR (1) | HRP20090647T1 (es) |
IL (1) | IL183564A0 (es) |
MX (1) | MX2007008114A (es) |
NO (1) | NO20074173L (es) |
PL (2) | PL372332A1 (es) |
PT (1) | PT1874745E (es) |
RS (1) | RS51215B (es) |
RU (1) | RU2369602C2 (es) |
SI (1) | SI1874745T1 (es) |
UA (1) | UA89940C2 (es) |
WO (1) | WO2006077206A1 (es) |
ZA (1) | ZA200705889B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL371841A1 (pl) * | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
EP1951692B1 (en) * | 2005-11-07 | 2010-08-18 | Irm Llc | Oxazole and thiazole ppar modulator |
WO2009132310A1 (en) * | 2008-04-25 | 2009-10-29 | Wisconsin Alumni Research Foundation | Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth |
AU2009323367B2 (en) * | 2008-12-01 | 2013-05-23 | Mitsubishi Tanabe Pharma Corporation | Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
SI3511319T1 (sl) * | 2014-07-03 | 2023-10-30 | Celgene Quanticel Research, Inc. | Inhibitorji lizin specifične demetilaze-1 |
US10080757B2 (en) | 2016-03-11 | 2018-09-25 | Wisconsin Alumni Research Foundation | Inhibitors of UDP-galactopyranose mutase |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552125A (en) | 1975-06-07 | 1979-09-05 | Lilly Industries Ltd | 2-acylamino oxazoles |
JPS58125039A (ja) | 1982-01-21 | 1983-07-25 | Konishiroku Photo Ind Co Ltd | 写真用2当量イエロ−カプラ− |
US5296486A (en) | 1991-09-24 | 1994-03-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Leukotriene biosynthesis inhibitors |
JPH07505647A (ja) | 1992-04-10 | 1995-06-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 複素環化合物および2型糖尿病の治療におけるそれらの使用 |
AU1961695A (en) | 1994-03-12 | 1995-10-03 | Yuhan Corporation | Triazole compounds and processes for the preparation thereof |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
RU2176999C2 (ru) | 1997-10-02 | 2001-12-20 | Санкио Компани, Лимитед | Производные амидокарбоновой кислоты, фармацевтическая композиция на их основе и способ снижения глюкозы в крови |
JP4618845B2 (ja) | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体 |
US6506781B1 (en) | 1999-09-08 | 2003-01-14 | Smithkline Beecham Corporation | Oxazole PPAR antagonist |
FR2808798A1 (fr) | 2000-05-09 | 2001-11-16 | Hoechst Marion Roussel Inc | Nouveaux derives antagonistes du recepteur de la vitronectine |
JP2004536152A (ja) | 2001-07-30 | 2004-12-02 | ノボ ノルディスク アクティーゼルスカブ | 新規ビニルn−(2−ベンゾイルフェニル)−l−チロシン誘導体及び抗糖尿病剤等へのそれらの使用 |
WO2003011834A1 (en) | 2001-07-30 | 2003-02-13 | Novo Nordisk A/S | Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
PL371841A1 (pl) | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
PL372356A1 (pl) | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
-
2005
- 2005-01-19 PL PL372332A patent/PL372332A1/pl unknown
-
2006
- 2006-01-12 US US11/332,709 patent/US7309791B2/en not_active Expired - Fee Related
- 2006-01-17 ES ES06703590T patent/ES2336358T3/es active Active
- 2006-01-17 EP EP06703590A patent/EP1874745B1/en active Active
- 2006-01-17 WO PCT/EP2006/050234 patent/WO2006077206A1/en active Application Filing
- 2006-01-17 UA UAA200709387A patent/UA89940C2/ru unknown
- 2006-01-17 SI SI200630532T patent/SI1874745T1/sl unknown
- 2006-01-17 AT AT06703590T patent/ATE448214T1/de active
- 2006-01-17 CA CA2590575A patent/CA2590575C/en not_active Expired - Fee Related
- 2006-01-17 JP JP2007551662A patent/JP2008527021A/ja active Pending
- 2006-01-17 DK DK06703590T patent/DK1874745T3/da active
- 2006-01-17 KR KR1020077018743A patent/KR100889447B1/ko not_active IP Right Cessation
- 2006-01-17 CN CNA2006800017398A patent/CN101098862A/zh active Pending
- 2006-01-17 PL PL06703590T patent/PL1874745T3/pl unknown
- 2006-01-17 DE DE602006010353T patent/DE602006010353D1/de active Active
- 2006-01-17 BR BRPI0606501-5A patent/BRPI0606501A2/pt not_active IP Right Cessation
- 2006-01-17 AU AU2006207492A patent/AU2006207492B8/en not_active Ceased
- 2006-01-17 RU RU2007131423/04A patent/RU2369602C2/ru not_active IP Right Cessation
- 2006-01-17 RS RSP-2010/0003A patent/RS51215B/sr unknown
- 2006-01-17 MX MX2007008114A patent/MX2007008114A/es active IP Right Grant
- 2006-01-17 PT PT06703590T patent/PT1874745E/pt unknown
-
2007
- 2007-03-06 US US11/714,984 patent/US7629370B2/en not_active Expired - Fee Related
- 2007-05-30 IL IL183564A patent/IL183564A0/en unknown
- 2007-07-18 ZA ZA200705889A patent/ZA200705889B/xx unknown
- 2007-08-14 NO NO20074173A patent/NO20074173L/no not_active Application Discontinuation
-
2009
- 2009-12-04 HR HR20090647T patent/HRP20090647T1/hr unknown
- 2009-12-30 CY CY20091101346T patent/CY1109678T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090647T1 (hr) | Novi derivati 3-fenilpropionske kiseline i nihova uporaba kao ppar-gama receptorskih liganada | |
JP2019510006A5 (es) | ||
AR089134A1 (es) | Arilos y heteroarilos biciclicos inhibidores de los canales de sodio | |
NO20081821L (no) | Forbindelser for behandling av metabolske forstyrrelser | |
JP2009529059A5 (es) | ||
HRP20100713T1 (hr) | Derivati azola i tiazola i njihova upotreba | |
HRP20140970T1 (hr) | Spoj azolkarboksamida ili njegova sol | |
ATE530066T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
NO20080058L (no) | Pyridazinonderivativer som tyroidhormon reseptoragonister | |
MX2009003535A (es) | Formas cristalinas de un compuesto de tiazolidinodiona, y metodos de fabricacion de las mismas. | |
RU2007126825A (ru) | Производные 2-арилпропиновой кислоты и фармацевтические композиции, их включающие | |
MX2009010790A (es) | Derivados de heteroarilo biciclico fusionados. | |
CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
NO20060502L (no) | Forbindelser for behandling av metabolske forstyrrelser | |
NZ592297A (en) | 2-Aryl-5-heteroaryl pyridine and pyrimidine derivatives as pharmaceutical active agents | |
JPWO2009038112A1 (ja) | Npyy5受容体拮抗剤を含有する固形製剤 | |
JP2010540462A5 (es) | ||
EA025199B1 (ru) | Гетероциклические соединения, подходящие для лечения дислипидемии | |
HRP20140588T1 (hr) | Spojevi kondenziranog prstena i njihova uporaba | |
RU2014119711A (ru) | Трициклические соединения, композиции, содержащие указанные соединения, и их применения | |
HRP20100079T1 (hr) | Novi derivati 3-fenilpropionske kiseline za liječenje dijabetesa | |
CA2666975A1 (en) | Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same | |
JPWO2020081257A5 (es) | ||
HRP20220232T1 (hr) | Amidni spojevi i njihova upotreba | |
JP2020517732A5 (es) |